Leiomyosarcoma Clinical Trials in New York, NY

Leiomyosarcoma Clinical Trials in New York, NY

View the best 10 leiomyosarcoma medical studies in New York, New York. Access promising new therapies by applying to a New York-based Leiomyosarcoma clinical trial.

Top rated leiomyosarcoma clinical trials in New York, New York

Here are the top 10 medical studies for leiomyosarcoma in New York, New York

Image of Massachusetts General Hospital in Boston, United States.

Doxorubicin +1 More

Alkylating agent

Recruiting1 awardPhase 1 & 2
This trial is studying if the combination of lurbinectedin with doxorubicin is safe and tolerable in people with soft tissue sarcoma. They will also compare the two to see which is more effective in treating leiomyosarcoma.
Image of Sarcoma Oncology Research Center in Santa Monica, United States.

Unesbulin +1 More

Chemotherapy

Recruiting0 awardsPhase 2 & 3
This trial will compare two different treatments for leiomyosarcoma, a type of cancer. One treatment will be the standard of care, and the other will be a new treatment that includes a drug called unesbulin. The trial will look at whether the new treatment is more effective and has fewer side effects than the standard treatment.
Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Talimogene Laherparepvec +1 More

Virus Therapy

Recruiting1 awardPhase 2
This trial is studying the side effects of talimogene laherparepvec and radiation therapy in treating patients with newly diagnosed soft tissue sarcoma.
Image of Columbia University/Herbert Irving Cancer Center in New York, United States.

Olaparib +1 More

PARP inhibitor

Recruiting1 awardPhase 2 & 3
This trial compares using a PARP inhibitor and alkylating agent to usual treatment for advanced uterine leiomyosarcoma after chemotherapy. The combo may be more effective.
Image of The Ottawa Hospital - General Campus in Ottawa, Canada.

Surgery

Recruiting2 awardsPhase 3
This trialtests if chemo before surgery can help people with a certain type of cancer live longer.
Image of Mayo Clinic Hospital in Phoenix, United States.

Doxorubicin

Anti-tumor antibiotic

Recruiting1 awardPhase 2
This trial is testing whether adding a new drug to standard treatment can help people with leiomyosarcoma that has spread to other parts of the body.
Image of Dana-Farber Cancer Institute in Boston, United States.

Ribociclib +1 More

CDK 4/6 Inhibitor

Recruiting1 awardPhase 2
This trial is testing a combination of two drugs, Ribociclib and Everolimus, to treat patients with advanced dedifferentiated liposarcoma or leiomyosarcoma who have had at least one prior systemic therapy. The drugs will be given orally, and the trial will last until disease progression, unacceptable toxicity, or withdrawal of consent.
Image of Washington University School of Medicine - Siteman Cancer Center in Saint Louis, United States.

ADI PEG20 +1 More

Enzyme Depletion

Recruiting1 awardPhase 3
This trial compares the effectiveness and safety of a new treatment for a type of cancer that has already had an existing treatment.
Image of Mayo Clinic Arizona in Phoenix, United States.

Anlotinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 3
This trial is currently recruiting patients with alveolar soft part sarcoma only and is no longer recruiting patients with synovial sarcoma or leiomyosarcoma.
Image of Sarcoma Oncology Center in Los Angeles, United States.

Doxorubicin +1 More

Anti-tumor antibiotic

Recruiting1 awardPhase 2 & 3
This trial will test if a combo of two chemo drugs can prolong progression-free survival in those with metastatic leiomyosarcoma.

Popular filter options for leiomyosarcoma new-york trials

Phase 3 Clinical Trials

View 13 phase 3 medical studies.

Clinical Trials With No Placebo

View 13 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.